Kaiser Permanente

Kaiser Permanente, established in 1945, is a leading American integrated managed care consortium, operating in eight states and the District of Columbia. It serves over 12 million members through its three main entities: Kaiser Foundation Health Plan, Kaiser Foundation Hospitals, and Permanente Medical Groups. The organization is renowned for its emphasis on preventive care, salaried physicians, and high-quality care, with over 39 hospitals and 700 medical offices. Kaiser Permanente Ventures, its corporate venture capital arm founded in 1997, invests in healthcare services, information technology, medical devices, diagnostics, and precision medicine, seeking to form strategic partnerships with innovative companies in these sectors.

Asriel Acosta

Director of Finance

Greg A. Adams

Chairman and CEO

Amy Raimundo

Managing Director and Vice President

Daniel Van Den Bergh

Senior Investment Director

Sam Brasch

Senior Managing Director; KP Venture

Olivia Capra

Senior Associate

Bechara Choucair MD

Senior Vice President and Chief Health Officer

Stephen Parodi

EVP, The Permanente Federation

Yvette Radford

Vice President

Liz Rockett

Managing Director

Jian Yu

Associate Chief Actuary

Ronald L. Copeland

Senior Vice President and Chief Equity, Inclusion and Diversity Office

149 past transactions

FACETS

Grant in 2025
FACETS is a Community Development Center that provide meals to individuals and families experiencing homelessness and food insecurity.

Fusion Partnerships

Grant in 2025
Fusion Partnerships is an organization that promotes joint action for social change and community development.

Innovaccer

Series F in 2025
Innovaccer Inc. is a technology company that specializes in developing analytical and data science applications primarily for the healthcare sector, along with industries such as financial services, manufacturing, and retail. The company offers a comprehensive Healthcare Intelligence Cloud that aggregates and analyzes patient data from various sources, including electronic health records and medical devices, to provide actionable insights. Its suite of solutions includes Datashop, which encompasses tools for patient care management, risk assessment in financial markets, and healthcare trend analysis. Innovaccer's platforms facilitate improved clinical workflows, care coordination, and operational efficiency by integrating functionalities for population health management and billing processes. Founded in 2012 and headquartered in Noida, India, with an office in Palo Alto, California, Innovaccer serves a diverse clientele, including academic institutions and governmental organizations, both domestically and internationally.

Black Directors Health Equity Agenda

Grant in 2024
Black Directors Health Equity Agenda works for the welfare of the Black people and other communities.

Clarium Health

Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.

Q Bio

Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in fields such as applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Habitat Health

Venture Round in 2024
Habitat Health is a healthcare company specializing in providing comprehensive health and social care services to older adults, enabling them to live independently in their homes and communities.

Vesta Healthcare

Venture Round in 2024
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.

Abridge

Series C in 2024
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.

Abridge

Series B in 2023
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.

Gynesonics

Venture Round in 2023
Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.

Healthcare Foundation Northern Sonoma County

Grant in 2023
Healthcare Foundation is a healthcare organization that provides patients with specialty surgical services.

Georgia Primary Care Association

Grant in 2023
Georgia Primary Care Association provides PCMH learning community, clinical quality program, family planning, and data center services.

Everytable

Series C in 2023
Everytable is a company focused on providing nutritious and affordable meals through grab-and-go locations. Its mission is to transform the food system to ensure that fresh, healthy food is accessible to everyone, regardless of their background. By operating a tech-driven casual restaurant platform, Everytable offers made-from-scratch meals at lower prices, achieved by streamlining traditional restaurant costs. This approach enables consumers to conveniently order wholesome food online, promoting greater access to healthy dining options in various communities.

DexCare

Series C in 2023
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.

NOCD

Series B in 2023
NOCD Inc. is a Chicago-based company that operates a mobile application designed to connect individuals with obsessive-compulsive disorder (OCD) to licensed mental health practitioners. Founded in 2014, the platform leverages cognitive behavioral therapy techniques, specifically exposure and response prevention exercises, to help users manage their symptoms. The application facilitates face-to-face video therapy sessions with therapists who specialize in OCD, while also providing 24/7 support through self-help tools and peer communities. NOCD aims to enhance the treatment experience for OCD patients by offering clinically supported resources and a comprehensive online platform dedicated to treatment and self-monitoring.

Born This Way Foundation

Grant in 2023
Born This Way Foundation they supports people and works with them to build an impact through programming, youth-led conversations, and strategic, cross-sectoral partnerships..

Validic

Venture Round in 2022
Validic, Inc. is a technology company specializing in a cloud-based platform that collects and manages mobile health data from various internet-enabled applications and devices. Founded in 2010 and based in Durham, North Carolina, Validic connects healthcare organizations with over 400 clinical and consumer devices, allowing for the integration of patient-recorded data into clinical workflows. Its primary offerings include Validic Solution, which links digital health data to healthcare providers; Validic Connect, which facilitates access to a broader range of clinical and consumer applications; and Validic Mobile, designed for data collection from health apps and in-home devices. The company serves a diverse clientele, including wellness companies, healthcare providers, pharmaceuticals, and health plans, with the goal of enhancing the quality of human life through actionable health data.

NorthOne

Series B in 2022
NorthOne Inc. provides digital banking solutions tailored for small businesses, startups, and freelancers. Founded in 2016 and headquartered in Toronto, Canada, with additional offices in New York and Boston, the company offers a mobile-first banking app that integrates various financial tools in a single platform. Users can manage their finances through features such as automated tax, payroll, and rent envelopes, and the ability to make deposits from anywhere. The app is accessible on iOS, Android, and desktop, ensuring a seamless banking experience while allowing businesses to focus more on their operations and community engagement.

Kate Farms

Series C in 2022
Kate Farms, Inc. is a company that specializes in producing vegan meal replacement shakes and tube feeding solutions for both adults and children. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company focuses on developing plant-based formulas that are easy to digest and made from organic ingredients. These products are designed to provide nutrition without common allergens or synthetic additives, making them suitable for individuals with various dietary restrictions and medical conditions. Kate Farms' offerings are available through both prescription and over-the-counter channels, and the company serves a wide range of patients, from those with severe chronic diseases to those with less serious health issues. Its products are distributed through a network of retail stores across the United States and online.

Incredible Health

Series B in 2022
Incredible Health, Inc. operates a technology-driven platform that connects healthcare providers with nursing professionals to address staffing challenges. Founded in 2015 and based in San Francisco, the company offers a subscription-based job portal that facilitates the recruitment process for medical candidates. This platform allows users, including fresh graduates, unemployed medical staff, and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Utilizing AI technology, Incredible Health custom matches healthcare organizations with qualified nurses for hard-to-fill positions, aiming to enhance the hiring experience and improve the lives of healthcare professionals.

Everytable

Series C in 2022
Everytable is a company focused on providing nutritious and affordable meals through grab-and-go locations. Its mission is to transform the food system to ensure that fresh, healthy food is accessible to everyone, regardless of their background. By operating a tech-driven casual restaurant platform, Everytable offers made-from-scratch meals at lower prices, achieved by streamlining traditional restaurant costs. This approach enables consumers to conveniently order wholesome food online, promoting greater access to healthy dining options in various communities.

Magnetic Insight

Series B in 2022
Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Ordr

Series C in 2022
Ordr, Inc. is a cybersecurity company that specializes in securing Internet of Things (IoT) devices. Founded in 2015 and based in Santa Clara, California, Ordr offers a platform that utilizes machine learning and deep packet inspection to identify and monitor every connected device within an enterprise. The company's Systems Control Engine, a software-as-a-service solution, autonomously classifies devices, regulates network traffic, and enforces access policies to enhance security. Ordr serves various industries, including healthcare, manufacturing, retail, public venues, and logistics, providing real-time asset inventory and addressing risks and compliance needs. Organizations around the world rely on Ordr's technology to safeguard their networks and streamline IT operations.

Tidelift

Series C in 2022
Tidelift specializes in enhancing the management and security of open-source software for professional developers. By offering a subscription service that partners directly with project maintainers, Tidelift provides a reliable source of proactively managed open-source components. The company's offerings include assurances related to security, licensing, and ongoing maintenance, which help businesses improve the overall quality of their software. This approach not only supports the sustainability of open-source projects but also accelerates the development of innovative software solutions.

Zepto

Series D in 2022
Zepto is an e-grocery company that specializes in the rapid delivery of daily essentials and grocery items directly to customers' doorsteps. Utilizing hyperlocal dark stores, Zepto stocks a variety of fresh produce, snack foods, and electronics, which can be conveniently ordered through its app or website. The company aims to provide a seamless online shopping experience, catering to the needs of customers seeking quick access to grocery products. By focusing on timely delivery, Zepto serves various sectors, including retail, food and beverage, and logistics.

IntelyCare

Series C in 2022
IntelyCare, Inc. is a healthcare staffing company based in Quincy, Massachusetts, founded in 2014. It provides an on-demand staffing platform that connects nursing professionals with post-acute healthcare facilities, enabling them to optimize staffing levels and manage workforce demands effectively. The platform allows nurses and nursing assistants to create their own schedules and select shifts that suit them, fostering a flexible work environment. Utilizing advanced data science and artificial intelligence, IntelyCare automates scheduling and improves the efficiency of filling nursing shifts, achieving rates three times the industry average. The company serves a variety of clients, including home care agencies, assisted living facilities, long-term care establishments, and rehabilitation hospitals, ultimately aiming to reduce burnout among nursing staff and enhance overall productivity. IntelyCare operates as a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC.

Osso VR

Series C in 2022
Osso VR, established in 2016 and headquartered in Palo Alto, California, specializes in developing a virtual reality surgical training platform. This platform enables medical professionals, including orthopedic surgeons and other specialists, to engage in realistic, haptic-enhanced simulations of surgical processes. It also provides analytical dashboards and personalized guidance for procedures. Osso VR caters to surgeons, sales teams, and medical trainees, offering immersive, hands-on experiences with the latest instruments, capital equipment, and surgical robotics.

Anyroad

Series B in 2022
AnyRoad Inc. operates a cloud-based platform that connects tourism customers with professional tour guides, facilitating the booking and management of various tours and experiences. Founded in 2012 and headquartered in San Francisco, California, the company serves multiple global locations, including Rio de Janeiro, San Francisco, New York, London, Tokyo, and Israel. AnyRoad specializes in experiential marketing, enabling businesses to enhance their events, tours, and other branded experiences to foster consumer loyalty and improve return on investment. The platform integrates with existing customer relationship management and point-of-sale systems, allowing brands to measure the impact of experiences on consumer perceptions and revenue growth, thereby optimizing their marketing strategies.

Secureframe

Series B in 2022
Secureframe, Inc., established in 2020 and headquartered in San Francisco, California, offers a compliance automation platform designed to assist organizations in achieving and maintaining compliance with various security and privacy standards. The platform automates compliance audits and facilitates ongoing monitoring, helping businesses manage their data securely and protect client privacy. Secureframe serves a diverse clientele, including fast-growing companies such as AngelList, Ramp, Remote, and Coda, by simplifying their compliance processes with global standards like SOC 2, ISO 27001, PCI DSS, HIPAA, and GDPR. This empowers businesses to build trust with customers through efficient and effective compliance management.

Big Health

Series C in 2022
Big Health is a digital therapeutics company headquartered in London, United Kingdom, that specializes in developing and marketing innovative behavioral health programs. The company's flagship product, Sleepio, is a digital sleep improvement program that employs Cognitive Behavioral Therapy techniques to address and personalize sleep disorders. By offering a fully automated healthcare portal, Big Health delivers highly personalized digital therapeutics and behavioral programs aimed at tackling various mental health issues. Their approach combines medical consultation with user-friendly technology, enabling individuals to effectively manage and overcome sleep-related disorders in an efficient manner.

DexCare

Series B in 2022
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.

Medically Home

Venture Round in 2022
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.

NOCD

Series B in 2021
NOCD Inc. is a Chicago-based company that operates a mobile application designed to connect individuals with obsessive-compulsive disorder (OCD) to licensed mental health practitioners. Founded in 2014, the platform leverages cognitive behavioral therapy techniques, specifically exposure and response prevention exercises, to help users manage their symptoms. The application facilitates face-to-face video therapy sessions with therapists who specialize in OCD, while also providing 24/7 support through self-help tools and peer communities. NOCD aims to enhance the treatment experience for OCD patients by offering clinically supported resources and a comprehensive online platform dedicated to treatment and self-monitoring.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Abogen Biosciences

Series C in 2021
Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.

OM1

Series D in 2021
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Spinny

Series D in 2021
Spinny is a technology-driven platform focused on the buying and selling of used cars, founded in 2015 and headquartered in Gurgaon, Haryana, India. The company aims to simplify the used car market by providing a trustworthy and hassle-free transaction experience. Spinny operates on a full-stack business model, ensuring value and transparency for its customers. Its platform features a selection of handpicked pre-owned vehicles, complete with detailed information, test drive options, and a five-day money-back guarantee. This approach allows car owners to list their vehicles while enabling potential buyers to navigate the purchasing process with ease and confidence.

Osso VR

Series B in 2021
Osso VR, established in 2016 and headquartered in Palo Alto, California, specializes in developing a virtual reality surgical training platform. This platform enables medical professionals, including orthopedic surgeons and other specialists, to engage in realistic, haptic-enhanced simulations of surgical processes. It also provides analytical dashboards and personalized guidance for procedures. Osso VR caters to surgeons, sales teams, and medical trainees, offering immersive, hands-on experiences with the latest instruments, capital equipment, and surgical robotics.

Protenus

Series D in 2021
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

PathAI

Series C in 2021
PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Medically Home

Corporate Round in 2021
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.

Groups Recover Together

Series C in 2021
Recover Together, Inc. operates private clinics that specialize in treating opioid addiction through a comprehensive approach that includes medication-assisted treatment and therapy. Founded in 2014 and headquartered in Manchester, New Hampshire, the company offers services across multiple states, including California, Indiana, Maine, Michigan, West Virginia, and North Carolina. Its treatment model combines the use of Suboxone (buprenorphine) with weekly group therapy sessions, allowing patients to engage in a supportive community while working toward their recovery goals. The organization is committed to making addiction treatment respectful, accessible, and affordable, empowering individuals to regain control of their lives and improve their overall quality of life.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.

Evidation Health

Series E in 2021
Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.

DexCare

Series A in 2021
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.

Nuvolo

Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

K Health

Series E in 2021
K Health, established in 2016, is a digital health company based in New York with an additional office in Israel. It offers a health application that uses AI to provide personalized, data-driven information about users' symptoms and health. The app covers a wide range of conditions, including back and neck pain, rashes, cold and flu symptoms, and chronic health issues like high blood pressure and asthma. By comparing users' symptoms and medical history with similar individuals, K Health helps users better understand and manage their health. The company's services are backed by prominent investors from the U.S. and Israel.

NewAmsterdam Pharma Company

Series A in 2021
NewAmsterdam Pharma, established in 2019 and headquartered in Naarden, the Netherlands, is a late-stage biopharmaceutical company dedicated to improving patient care in cardio-metabolic disease populations. The company's primary focus is the development of transformative therapies, with its lead product, obicetrapib, being a next-generation, oral, low-dose CETP inhibitor designed to lower LDL-C levels more effectively than current treatments, particularly for patients with statin intolerance or Arteriosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally-tolerated statin therapy.

dMed

Series C in 2020
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

Everytable

Series B in 2020
Everytable is a company focused on providing nutritious and affordable meals through grab-and-go locations. Its mission is to transform the food system to ensure that fresh, healthy food is accessible to everyone, regardless of their background. By operating a tech-driven casual restaurant platform, Everytable offers made-from-scratch meals at lower prices, achieved by streamlining traditional restaurant costs. This approach enables consumers to conveniently order wholesome food online, promoting greater access to healthy dining options in various communities.

Kate Farms

Series B in 2020
Kate Farms, Inc. is a company that specializes in producing vegan meal replacement shakes and tube feeding solutions for both adults and children. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company focuses on developing plant-based formulas that are easy to digest and made from organic ingredients. These products are designed to provide nutrition without common allergens or synthetic additives, making them suitable for individuals with various dietary restrictions and medical conditions. Kate Farms' offerings are available through both prescription and over-the-counter channels, and the company serves a wide range of patients, from those with severe chronic diseases to those with less serious health issues. Its products are distributed through a network of retail stores across the United States and online.

Osso VR

Series A in 2020
Osso VR, established in 2016 and headquartered in Palo Alto, California, specializes in developing a virtual reality surgical training platform. This platform enables medical professionals, including orthopedic surgeons and other specialists, to engage in realistic, haptic-enhanced simulations of surgical processes. It also provides analytical dashboards and personalized guidance for procedures. Osso VR caters to surgeons, sales teams, and medical trainees, offering immersive, hands-on experiences with the latest instruments, capital equipment, and surgical robotics.

Truepill

Series C in 2020
Truepill is a B2B pharmacy fulfillment service headquartered in San Mateo, California. Founded in 2016 by Umar Afridi and Sid Viswanathan, the company provides a pharmacy API and medication fulfillment to customers across all 50 states from its own facilities. Truepill collaborates with direct-to-consumer brands, digital health companies, and various healthcare organizations to enhance the pharmacy experience. Its technology offers real-time visibility into patients, prescriptions, and order details, facilitating payment flexibility and delivery tracking. With a team of 150 employees, Truepill has attracted investment from several notable investors, including Initialized Capital and Y Combinator.

Ginger

Series D in 2020
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Genome Medical

Series B in 2020
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and headquartered in New York, United States.

Big Health

Series B in 2020
Big Health is a digital therapeutics company headquartered in London, United Kingdom, that specializes in developing and marketing innovative behavioral health programs. The company's flagship product, Sleepio, is a digital sleep improvement program that employs Cognitive Behavioral Therapy techniques to address and personalize sleep disorders. By offering a fully automated healthcare portal, Big Health delivers highly personalized digital therapeutics and behavioral programs aimed at tackling various mental health issues. Their approach combines medical consultation with user-friendly technology, enabling individuals to effectively manage and overcome sleep-related disorders in an efficient manner.

Orca Bio

Series D in 2020
Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients suffering from malignant and autoimmune diseases. The company has developed proprietary technologies aimed at replacing diseased blood and immune systems with healthy cells. Orca Bio specializes in the research and development of innovative cell therapies that enhance the effectiveness of bone marrow transplants, creating a life-saving platform for various medical conditions. With a team of leading experts and technologists, Orca Bio is committed to advancing its pipeline of therapies to improve patient outcomes and transform healthcare practices.

Ordr

Series B in 2020
Ordr, Inc. is a cybersecurity company that specializes in securing Internet of Things (IoT) devices. Founded in 2015 and based in Santa Clara, California, Ordr offers a platform that utilizes machine learning and deep packet inspection to identify and monitor every connected device within an enterprise. The company's Systems Control Engine, a software-as-a-service solution, autonomously classifies devices, regulates network traffic, and enforces access policies to enhance security. Ordr serves various industries, including healthcare, manufacturing, retail, public venues, and logistics, providing real-time asset inventory and addressing risks and compliance needs. Organizations around the world rely on Ordr's technology to safeguard their networks and streamline IT operations.

IntelyCare

Series B in 2020
IntelyCare, Inc. is a healthcare staffing company based in Quincy, Massachusetts, founded in 2014. It provides an on-demand staffing platform that connects nursing professionals with post-acute healthcare facilities, enabling them to optimize staffing levels and manage workforce demands effectively. The platform allows nurses and nursing assistants to create their own schedules and select shifts that suit them, fostering a flexible work environment. Utilizing advanced data science and artificial intelligence, IntelyCare automates scheduling and improves the efficiency of filling nursing shifts, achieving rates three times the industry average. The company serves a variety of clients, including home care agencies, assisted living facilities, long-term care establishments, and rehabilitation hospitals, ultimately aiming to reduce burnout among nursing staff and enhance overall productivity. IntelyCare operates as a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.

Ginger

Series C in 2019
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Protenus

Series C in 2019
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Polarity

Series A in 2019
Polarity is a computer software company focused on enhancing collaboration and decision-making in information technology. It offers a memory augmentation platform that analyzes the content displayed on users' computer screens, providing real-time access to relevant information without disrupting their existing workflow. The platform also integrates data from external sources, enabling organizations to make more informed and timely decisions through on-screen overlays. Polarity aims to streamline the process of information retrieval and improve efficiency across teams and workflows.

Freenome

Series B in 2019
Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Nuvolo

Series B in 2019
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

Omada

Series D in 2019
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Health Catalyst

Series F in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.

Multisensor Diagnostics

Seed Round in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

CareAcademy

Seed Round in 2018
CareAcademy is an online training provider dedicated to empowering senior care professionals through specialized education. Its platform offers a range of courses covering essential topics such as infection control, nutrition, meal preparation, dementia care, fall prevention, and safe transfers. With over 250,000 direct care workers utilizing its services, CareAcademy aims to enhance the skills and knowledge of caregivers, ultimately improving the quality of care for older adults. The company also features an advanced reporting, training, and compliance management dashboard, providing a comprehensive and scalable training solution that helps transform home care businesses into industry leaders.

Protenus

Series B in 2018
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Genome Medical

Series A in 2018
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Collective Medical

Series A in 2017
Collective Medical operates a real-time collaboration software platform for healthcare providers, connecting hospitals, clinics, health plans, and community organizations to share patient information and improve care coordination. The platform, used by hundreds of hospitals, health plans, and tens of thousands of providers nationwide, helps identify at-risk patients and facilitates collaborative care decisions, reducing emergency department visits and avoidable readmissions. Based in Salt Lake City, Collective Medical was founded in 2005 and is now a subsidiary of PointClickCare Corp.

Protenus

Series A in 2017
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Chrono Therapeutics

Series B in 2016
Chrono Therapeutics Inc. is a pharmaceutical company based in Hayward, California, specializing in digital transdermal drug delivery systems. Founded in 2003, the company has developed SmartStop, a digital nicotine replacement therapy that incorporates a wearable device. This innovative solution allows for programmable delivery of nicotine, adjusting timing and dosage to effectively manage withdrawal symptoms and peak addiction triggers. By combining this transdermal therapy with real-time behavioral support, Chrono Therapeutics aims to enhance smoking cessation efforts and improve clinical outcomes for users. The leadership team brings extensive experience in product development, research and development, and a deep understanding of the smoking cessation market, positioning the company to play a significant role in addressing the smoking epidemic.

Big Health

Series B in 2016
Big Health is a digital therapeutics company headquartered in London, United Kingdom, that specializes in developing and marketing innovative behavioral health programs. The company's flagship product, Sleepio, is a digital sleep improvement program that employs Cognitive Behavioral Therapy techniques to address and personalize sleep disorders. By offering a fully automated healthcare portal, Big Health delivers highly personalized digital therapeutics and behavioral programs aimed at tackling various mental health issues. Their approach combines medical consultation with user-friendly technology, enabling individuals to effectively manage and overcome sleep-related disorders in an efficient manner.

Torax Medical

Series E in 2016
Torax Medical, Inc. is a clinical-stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters to treat various digestive diseases. Its primary offerings include LINX, a reflux management system designed for patients with gastroesophageal reflux disease (GERD), and FENIX, a continence restoration system for fecal incontinence. Utilizing specialized magnets, these devices facilitate minimally invasive procedures to address these conditions. Torax Medical operates in both the European and U.S. markets and is a subsidiary of Ethicon, Inc.

Bluesight

Series C in 2016
Bluesight operates as a healthcare technology company specializing in supply chain optimization for pharmaceuticals. It offers Medication Intelligence solutions that provide real-time analytics across the entire medication lifecycle, enhancing efficiency, reducing risks, and improving patient safety within hospitals. The core product is an inventory management platform that automates pharmacy kit processing and medication tracking, replacing manual processes to increase operational efficiency and medication visibility.

CareGuardian

Series B in 2016
CareGuardian, founded in 2014, specializes in providing caregiver services for elderly patients, emphasizing the importance of both professional and family caregivers in delivering exceptional support for older adults. The company offers a user-centric technology platform developed in-house, which connects caregivers, clinicians, and care managers. This innovative approach aims to empower caregivers and ensure that seniors can age safely and remain engaged with their communities while receiving the necessary care at home. By focusing on training and support, CareGuardian seeks to enhance the visibility and recognition of caregivers, fostering a more effective caregiving environment.

Vidyo

Series E in 2015
Vidyo, Inc. specializes in high-definition video conferencing software that facilitates universal visual communication. Its suite of products includes VidyoDesktop, which allows users on Windows, Mac, and Linux to engage in video conferences from various locations, and VidyoWeb, a browser extension enabling conference participation from desktop and laptop computers. Additionally, VidyoRoom Solutions offer tailored in-office video conferencing experiences for hybrid teams, while VidyoMobile provides high-quality conferencing capabilities for mobile devices. VidyoSlate allows users to share and annotate content during conferences. The company serves diverse sectors including healthcare, education, government, and enterprise, emphasizing the importance of video communication in enhancing productivity and collaboration. Founded in 2005 and headquartered in Hackensack, New Jersey, Vidyo has expanded its presence worldwide with offices in multiple countries. As of 2019, it operates as a subsidiary of Enghouse Systems Limited.

Group Health Cooperative

Acquisition in 2015
Group Health Cooperative is a member-governed, non-profit healthcare organization that coordinates care and coverage. The organization offers health plans for individuals and families; state and federal employees; and employers such as small and large groups including employer-sponsored group plans. It also provides various specialty care services at its medical centers in contracted hospitals; and healthcare, pharmacy, and drug formulary services. In addition, Group Health Cooperative conducts non-proprietary public-interest research on preventing, diagnosing, and treating major health problems in the areas of aging and geriatrics, health services and economics, alternative approaches to healing, healthy communities, behavior change, medication use and patient safety, biostatistics, mental health, cancer, obesity, cardiovascular health, preventive medicine, child and adolescent health, vaccines and infectious diseases, chronic illness management, women’s health, and health informatics. Group Health Cooperative was founded in January 1947 and is based in Seattle, Washington with administrative offices in Tukwila, Bellingham, Spokane, Tacoma, and Kennewick, Washington.

Vapotherm

Series C in 2015
Vapotherm, Inc. is a medical technology company specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients of all ages experiencing respiratory distress. Headquartered in Exeter, New Hampshire, the company offers a range of precision flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through a small-bore nasal interface. Vapotherm also provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air, and aerosol solutions for medication delivery. Additionally, the company offers disposable products, including single-use nasal interfaces and Oxygen Assist Modules to help clinicians maintain target oxygen levels. Vapotherm generates revenue primarily through direct sales to hospitals in the United States and through distributors in select international markets. Founded in 1993, the company is committed to enhancing clinical outcomes and improving the quality of life for patients.

Vapotherm

Series C in 2015
Vapotherm, Inc. is a medical technology company specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients of all ages experiencing respiratory distress. Headquartered in Exeter, New Hampshire, the company offers a range of precision flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through a small-bore nasal interface. Vapotherm also provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air, and aerosol solutions for medication delivery. Additionally, the company offers disposable products, including single-use nasal interfaces and Oxygen Assist Modules to help clinicians maintain target oxygen levels. Vapotherm generates revenue primarily through direct sales to hospitals in the United States and through distributors in select international markets. Founded in 1993, the company is committed to enhancing clinical outcomes and improving the quality of life for patients.

Validic

Series B in 2015
Validic, Inc. is a technology company specializing in a cloud-based platform that collects and manages mobile health data from various internet-enabled applications and devices. Founded in 2010 and based in Durham, North Carolina, Validic connects healthcare organizations with over 400 clinical and consumer devices, allowing for the integration of patient-recorded data into clinical workflows. Its primary offerings include Validic Solution, which links digital health data to healthcare providers; Validic Connect, which facilitates access to a broader range of clinical and consumer applications; and Validic Mobile, designed for data collection from health apps and in-home devices. The company serves a diverse clientele, including wellness companies, healthcare providers, pharmaceuticals, and health plans, with the goal of enhancing the quality of human life through actionable health data.

Health Catalyst

Series D in 2015
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Bluesight

Series B in 2015
Bluesight operates as a healthcare technology company specializing in supply chain optimization for pharmaceuticals. It offers Medication Intelligence solutions that provide real-time analytics across the entire medication lifecycle, enhancing efficiency, reducing risks, and improving patient safety within hospitals. The core product is an inventory management platform that automates pharmacy kit processing and medication tracking, replacing manual processes to increase operational efficiency and medication visibility.

Ingenious Med

Venture Round in 2015
Ingenious Med, Inc. is a provider of cloud-based patient encounter and practice management systems tailored for the healthcare industry in the United States. Founded in 1999 and headquartered in Atlanta, Georgia, the company offers a comprehensive platform that includes tools for charge capture, care coordination, and advanced analytics. Its products, accessible through web and mobile applications, support inpatient physicians with functionalities such as digital communication, e-prescribing, and performance measurement. Ingenious Med's offerings also include coding and compliance tools, business intelligence tools, and back-office solutions that facilitate billing and coding processes. The company caters to a diverse clientele, including physician groups, academic institutions, healthcare systems, and management companies, and provides training and implementation services to enhance user adoption and effectiveness.

Ginger

Series B in 2014
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

MetricStream

Venture Round in 2014
MetricStream, Inc. is a leading provider of governance, risk, and compliance (GRC) software solutions, offering both cloud-based and on-premise applications. Founded in 1999 and headquartered in Palo Alto, California, the company serves a diverse range of industries, including banking, healthcare, automotive, and energy. Its software platform encompasses various functions such as internal audits, regulatory compliance, risk management, quality assurance, and vendor governance, enabling organizations to enhance their business performance and make informed decisions amidst regulatory complexities. MetricStream's solutions facilitate the integration of governance, risk management, and compliance across organizations, empowering users to navigate risks effectively while pursuing growth opportunities. With a commitment to customer support, implementation, and training, MetricStream continues to strengthen its presence in the global market through strategic partnerships and a robust portfolio of services.

Valeritas Holdings

Series D in 2014
Valeritas Holdings, Inc. was a medical technology company focused on developing and commercializing innovative solutions for the treatment of Type 2 diabetes. Founded in 2006 and headquartered in Bridgewater, New Jersey, the company offered the V-Go, a wearable insulin delivery device designed for basal-bolus therapy, allowing patients to manage their insulin intake conveniently and discreetly. Valeritas was also working on additional products, including the V-Go Prefill, aimed at simplifying the device-filling process, and V-Go SIM, which would facilitate real-time tracking of dosing utilization. The company marketed its products through third-party wholesalers and medical supply distributors, aiming to enhance the health and quality of life for individuals living with diabetes. However, on June 30, 2020, Valeritas Holdings filed for Chapter 11 bankruptcy, leading to its cessation of operations.

Omada

Series B in 2014
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Vapotherm

Series B in 2014
Vapotherm, Inc. is a medical technology company specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients of all ages experiencing respiratory distress. Headquartered in Exeter, New Hampshire, the company offers a range of precision flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through a small-bore nasal interface. Vapotherm also provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air, and aerosol solutions for medication delivery. Additionally, the company offers disposable products, including single-use nasal interfaces and Oxygen Assist Modules to help clinicians maintain target oxygen levels. Vapotherm generates revenue primarily through direct sales to hospitals in the United States and through distributors in select international markets. Founded in 1993, the company is committed to enhancing clinical outcomes and improving the quality of life for patients.

Transcend Medical

Series C in 2014
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.

Health Catalyst

Series C in 2014
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

TriVascular

Series E in 2013
TriVascular Technologies, Inc. is a medical device company focused on developing and commercializing technologies for the minimally invasive treatment of abdominal aortic aneurysms (AAA) and thoracic aortic conditions. The company is known for its Ovation System, which includes a stent graft platform designed for endovascular aortic repair. Key components of the Ovation System feature an aortic body, iliac limbs, and polymer fill, which contribute to its effectiveness in treating AAA. TriVascular markets its products through direct sales in the United States and several European countries, as well as via distributors in other regions. Founded in 2007 and headquartered in Santa Rosa, California, TriVascular has been recognized for its innovative approach to addressing unmet clinical needs in aortic disease treatment. The company operates as a subsidiary of Endologix Inc.

Xanitos

Venture Round in 2013
Xanitos, Inc. is a contracted environmental services provider specializing in hospital housekeeping, patient transportation, and central laundry services across the United States. Founded in 2008 and based in Newtown Square, Pennsylvania, the company focuses on cleaning both patient and non-patient areas within healthcare facilities and managing linen distribution. Xanitos offers comprehensive linen and laundry management services, including the development of usage policies and protocols, assessments of linen utilization, and evaluations of logistics related to clean linen distribution. The company is recognized for its innovative XRO system for cleaning patient rooms and is led by founder and CEO Graeme Crothall, who has extensive experience in the industry. Xanitos aims to enhance patient satisfaction by improving cleaning quality, increasing healthcare satisfaction scores, reducing hospital-acquired infections, and lowering bed turnaround times, all while maintaining a commitment to high-quality service.

Movable

Seed Round in 2013
Movable specializes in the development of wrist-worn activity monitors, primarily through its product MOVband, which tracks all types of movement rather than just steps. The company aims to support corporate and school-based wellness programs by providing tools that encourage physical activity. In addition to the MOVband, Movable also offers MOVchallenge, a social-activity program designed to motivate users through rewards and sharing of information. This dual approach fosters a community around health and wellness, making it easier for participants to engage in and sustain active lifestyles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.